Adaptive Biotechnologies and Microsoft team up to track coronavirus-fighting cells

GeekWire

Seattle-based Adaptive Biotechnologies and Microsoft have launched an open-access database called ImmuneCODE to catalog the many ways in which our immune systems fight off a coronavirus infection. Check out this GeekWire Health Tech Podcast for more about Adaptive Biotechnologies’ collaboration with Microsoft on COVID-19 studies. Health/Life Sciences Science Adaptive Biotechnologies coronavirus immune system immune therapy ImmuneCODE Microsoft Microsoft Health

Adaptive Biotechnologies posts $26.3M in Q3 revenue, inks partnership with GlaxoSmithKline

GeekWire

Adaptive Biotechnologies CEO Chad Robins. Adaptive Biotechnologies beat expectations for its fiscal third quarter as the Seattle company continues to use its immune medicine platform in the fight against COVID-19. Tech Adaptive Biotechnologies

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Adaptive Biotechnologies will sell 8M shares to accelerate drug development

GeekWire

Adaptive Biotechnologies announced Tuesday that it will sell 8 million shares of its common stock — 6 million of its own, and 2 million from an investor — to help accelerate the company’s work. Health/Life Sciences Adaptive BiotechnologiesThe money will go toward investments in its TCR-Antigen Map activities, marketing activities associated with immunoSEQ Dx clinical products and services, and continued R&D for drug discovery initiatives.

Machine learning and microbes: How big data is redefining biotechnology

Tech Republic Big Data

As interesting as big data can be in Silicon Valley, its most fascinating applications often happen elsewhere

Living algae facades cover buildings, sucking in CO2 and sun to produce renewable energy

Mashable VR

More about Design , Renewable Energy , Facade , Algae , and Biotechnology. Design Renewable Energy Facade Algae Biotechnology

Adaptive plans fall launch of T-cell test for past COVID-19 detection, as alternative to antibody tests

GeekWire

Adaptive Biotechnologies says it’s proceeding with plans to launch a new type of test to determine if someone was previously infected with SARS-CoV-2, the virus that causes COVID-19, after a study added to the evidence that its approach is more accurate than currently available antibody tests.

Tech Moves: Amazon’s director of Alexa Trust; BECU adds CIO; Lockstep, Fabric exit stealth mode

GeekWire

Andris Zoltners stepped down from the board of publicly traded Seattle-based Adaptive Biotechnologies after 11 years. . Nautilus Biotechnology Photo). Anne Toth. Amazon Photo).

This 35-year-old female CEO is about to crack the glass ceiling, shattering a dismal IPO track record

GeekWire

The 35-year-old co-founder and CEO of Seattle biotechnology company Athira Pharma would be the first woman to guide a company to an initial public offering in Washington state in more than two decades. ” Startups Athira Pharma Biotechnology IPOs leen kawas

Researcher with Seattle ties awarded $4.2M to develop DNA vaccine against COVID-19

GeekWire

OncoSenX is the spinoff of a third company, Seattle-based Oisin Biotechnologies. Tech Biotech Biotechnology COVID-19 COVID-19 vaccine oncosenxJohn Lewis, co-founder and chief scientific officer at Seattle’s OncoSenX, and co-founder and CEO of Entos Pharmaceuticals in Edmonton, Alberta. LinkedIn Photo). A researcher with ties to Seattle-based biotech company OncoSenX has received a $4.2

Merck’s multi-billion dollar bet on Seattle Genetics sparks hope for breast cancer treatments

GeekWire

based biotechnology company struck a deal with Merck in which the pharmaceutical powerhouse will provide a $600 million upfront payment and make a $1 billion equity investment to continue development of treatments for breast cancer. Health/Life Sciences Biotechnology Seattle Genetics

Industry slowdown hits Adaptive Biotech’s bottom line as COVID immune initiatives show progress

GeekWire

Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the company’s chief scientific officer. Adaptive Biotechnologies Photo).

.Net 60

Adaptive Biotech revenue rises 65% to $21M, loss widens amid big COVID-19 immune partnerships

GeekWire

Adaptive Biotechnologies CEO Chad Robins. Adaptive Biotechnologies, which is working with Microsoft and Amgen to fight COVID-19 using its technology for sequencing the human immune system, reported a 65% increase in first quarter revenue , to nearly $21 million. Health/Life Sciences Adaptive Biotechnologies Amgen chad robinsGeekWire File Photo).

Inside the quest for a new COVID-19 test: Microsoft, Adaptive Biotech and the hidden power of immunity

GeekWire

Two companies in the Seattle region, Microsoft and Adaptive Biotechnologies, are on a quest to create a better diagnostic test. Health Tech Podcast Adaptive Biotechnologies chad robins COVID-19 Microsoft Peter LeeAdaptive Biotech CEO Chad Robins (left) and Peter Lee, Microsoft corporate vice president of AI and Research, on a video call this week for GeekWire’s Health Tech Podcast.

Study 63

Secretive Seattle biotech company raises more than $700M to develop new ways to modify genes

GeekWire

Sana Biotechnology today formally announced that it has raised more than $700 million in venture funding — one of the largest venture financing deals in the life sciences industry and one of the biggest rounds on record in Seattle. Health/Life Sciences Biotechnology Funding fundings sana Venture capitalSteve Harr (Sana Photo).

GeekWire Podcast: What pandemic? Tech funding stays strong; Accolade’s IPO; Future of sports

GeekWire

Health/Life Sciences Podcasts Startups Accolade Funding GeekWire Events IPO Sana BiotechnologyHere’s what we’re talking about on the GeekWire Podcast this week. Despite the pandemic, funding for Pacific Northwest tech startups remains robust in the first half of 2020. In fact, funding is ahead of last year. What gives? We consider whether COVID-19 is accelerating some companies into the new economy of remote working, online shopping and heightened awareness of health and life sciences.

Harry Potter's invisibility cloak is almost a reality, but only for likely military use

Mashable VR

Canadian camouflage company Hyperstealth Biotechnology is working on a 'cloak' that can render some objects nearly invisible from certain angles. The cloak uses a technology called Quantum Stealth to bend light around people or objects.

Seattle biotech firm Umoja Biopharma raises $53M as it tackles unique approach to immunotherapy

GeekWire

Others include Sana Biotechnology, Chinook Therapeutics, Kineta, Alpine Immune Sciences, Adaptive Biotechnologies, and more, in addition to work being done at Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Benaroya Research Institute, and others.

Scientists find more potential ingredients for ‘antibody cocktail’ that fights COVID-19

GeekWire

UW’s David Veesler and Vir Biotechnology’s Katja Fink are the senior authors of the study published online today by the journal Science , which highlights two monoclonal antibodies known as S2E12 and S2M11. A drug that takes advantage of S309’s effect is already being tested in a phase 2/3 clinical trial launched by GlaxoSmithKline and Vir Biotechnology.

Seattle biotech Athira Pharma sets terms for IPO, aims to raise up to $170M

GeekWire

Formerly known as M3 Biotechnology, the company is led by Leen Kawas, a 35-year-old CEO who would be the first woman to guide a company to an initial public offering in Washington state in more than two decades.

Seattle biotech startup OncoSenX raising more cash for cancer-fighting therapies

GeekWire

OncoSenX is a spinout out of Oisin Biotechnologies, a 5-year-old Seattle company also led by Scholz, a veteran biotech entrepreneur. Biotech startup OncoSenX is raising more cash to help support its pipeline of therapeutics that aim to kill cancer cells based on their genetics. Its technology targets solid tumors based on a patented lipid nanoparticle gene delivery system and a highly targeted DNA payload.

A SPAC called FLAC? Seattle venture capital firm to launch $100 million ‘blank check’ company

GeekWire

Frazier Healthcare Partners — which has invested in biotechnology companies since 1991 — filed with the Securities and Exchange Commission to raise $100 million for a special purpose acquisition corporation, also known as a SPAC. James Topper serves as CEO Of FLAC. Photo via Frazier).

Athira Pharma prices IPO at $17/share, will raise $204M in third Washington state IPO of 2020

GeekWire

Formerly known as M3 Biotechnology, the company is led by Dr. Leen Kawas , a 35-year-old CEO who will be the first woman to guide a company to an initial public offering in Washington state in more than two decades. The Athira team. Athira Photo).

Seattle biotech startup led by Fred Hutch, Adaptive vets raises $16M for rapid drug development tech

GeekWire

Lumen is led by Finrow, a former senior vice president at Adaptive Biotechnologies, and Chief Science Officer Jim Roberts , the former head of basic sciences at the Fred Hutchinson Cancer Research Institute. Lumen Chief Science Officer Jim Roberts (left) and CEO Brian Finrow. Lumen Photo).

Sana CEO reveals details about stealthy gene therapy startup that has raised more than $700M

GeekWire

Luke Timmerman interviews Sana Biotechnology CEO Steve Harr at the GeekWire Summit this week. Harr spoke with biotechnology journalist Luke Timmerman, founder of The Timmerman Report , this week at the GeekWire Summit. Luke Timmerman (left) interviews Sana Biotechnology CEO Steve Harr.

Arizona State University Adopts Hortonworks Data Platform to Shed Light on the Genetic Links to Cancer

CTOvision

ASU researcher improves crop performance with new biotechnology (eurekalert.org). Katie Kennedy. Recently announced, Arizona State University (ASU) is using Hortonworks Data Platform (HDP™) to further cancer research. With HDP, ASU researchers have the tools they need to store, process, and query more data at a faster pace, allowing researchers to ask better questions and uncover new links between genetics and cancer.

Seattle biotech startup Athira raises $85M to develop therapies for Alzheimer’s and Parkinson’s

GeekWire

The company, previously known as M3 Biotechnology, is committed to growing in Seattle as part of the local biotech and life sciences ecosystem , Kawas said. Other fast-growing Seattle-area biotech startups include Nautilus Biotechnology, which just raised a $76 million Series B round to study the human proteome, Silverback Therapeutics, Phase Genomics, Good Therapeutics, Blaze Bioscience, and more. The Athira team. Athira Photo).

Scientists say 17-year-old blood sample yields promising antibodies for COVID-19

GeekWire

Medications that make use of the antibodies are now on a fast-track development and testing path at California-based Vir Biotechnology in collaboration with GlaxoSmithKline , in preparation for clinical trials. The search for COVID-19 therapies has turned to an antibody that was first identified back in 2003, in a blood sample from a patient who recovered from a similar coronavirus-based disease.

Seattle’s Athira Pharma files for IPO to fund quest for Alzheimer’s and Parkinson’s breakthroughs

GeekWire

The company, previously known as M3 Biotechnology, is led by Dr. Leen Kawas , a 35-year-old entrepreneur originally from Jordan. It would be the first Seattle biotech to go public since Adaptive Biotechnologies IPO’d last year. The Athira team. Athira Photo).

Microsoft releases preview of Text Analytics for health, battle-tested in COVID-19 partnership

GeekWire

” It’s the latest in a series of initiatives from Microsoft that apply artificial intelligence to health, life sciences and biotechnology. Bigstock Photo. Microsoft’s Azure cloud platform announced a new iteration of its Text Analytics technology for healthcare, bringing to market some of the artificial intelligence that the company previously contributed to an industry partnership to develop a COVID-19 search engine for researchers.

Next-gen vaccine from UW researchers shows promise in fighting COVID-19

GeekWire

LION was developed by the Seattle biotechnology company HDT Bio; Amit P. Deborah Fuller, left, and Jesse Erasmus are pursuing next-generation vaccines at the University of Washington. GeekWire Photo / Todd Bishop).

Thanks Darpa: Minimally Invasive “Stentrode” Shows Potential as Neural Interface for Brain

CTOvision

In an article published in Nature Biotechnology , researchers in the Vascular Bionics Laboratory at the University of Melbourne led by neurologist Thomas Oxley, M.D., Bob Gourley. DARPA funded research has produced a device, called the "stentrode," capable of direct recording of brain activity, right from neurons. This amazing technology repurposes stent devices to enable this breakthrough. .

Fred Hutch and Allen Institute launch study of milder COVID-19 cases, aiming for unique insights

GeekWire

Adaptive Biotechnologies, for example, is using its immune sequencing platform in partnerships with Microsoft and Amgen in search of better COVID-19 tests and therapies.

Study 109

Bill Gates and Jeff Bezos-backed cancer detection company Grail, led by ex-Juno CEO, files for IPO

GeekWire

Bezos and Vulcan Capital, the firm founded by the late Microsoft co-founder Paul Allen, are backers of a similar Seattle startup called Nautilus Biotechnology that raised $76 million in May. Grail CEO Hans Bishop at the 2016 GeekWire Summit. GeekWire Photo / Dan DeLong).

Microsoft joins new industry alliance aimed at advancing DNA data storage systems

GeekWire

In addition to the founders, these 10 organizations were listed today as members of the DNA Data Storage Alliance, and more organizations are being recruited: Ansa Biotechnologies.

GeekWire Summit Preview: A glimpse of the future of tech, health, education, jobs and more

GeekWire

Thursday, October 22: Education and Sana Biotechnology. Regence Health Tech Stage: Fireside chat with Steve Harr, CEO of Sana Biotechnology. Our signature technology conference, the GeekWire Summit , kicks off next week.

Pacific NW startup funding totals for first half of 2020 may surprise you — in fact, they shocked us

GeekWire

As the chart at top shows, there was one whopper financing in June: Seattle-based Sana Biotechnology raised more than $700 million in one of the largest biotechnology funding deals ever. Recession? What recession?

Good Therapeutics raises $11M to develop ‘context dependent’ protein drugs

GeekWire

Another Seattle biotech company, Nautilus Biotechnology, announced a $76 million funding round Thursday. Good Therapeutics CEO John Mulligan. Good Therapeutics Photo). Seattle biotech startup Good Therapeutics raised another $11 million to create “context dependent” protein drugs that act only when needed. The 4-year-old company is developing cytokines that regulate their own activity in response to biomarkers and metabolic signals, said CEO John Mulligan.

Chinook Therapeutics to merge with Aduro Biotech as it pushes forward with kidney disease therapies

GeekWire

He was COO at Seattle Genetics for 15 years and currently is a board member at Adaptive Biotechnologies and Atara Biotherapeutics. Chinook Therapeutics , a biotech company creating targeted therapies for kidney diseases, has agreed to merge with Berkeley, Calif.-based based Aduro Biotech. The proposed all-stock deal “is a unique opportunity for Chinook to build a leading company in the kidney disease space,” Chinook CEO Eric Dobmeier said in a statement.

Virtual primary care startup 98point6 raises $118M as pandemic sparks demand for digital health tech

GeekWire

The round is one of the largest for a Seattle-area startup this year and the latest in a string of recent $100 million-plus investments in companies such as Qumulo, Auth0, Sana Biotechnology, and others.

Stock market rally: Amazon, Microsoft, other Seattle companies bounce back from March lows

GeekWire

Other Seattle-area companies seeing shares increase include Adaptive Biotechnologies (130%); Impinj (123%); Avalara (70%); Smartsheet (40%); and T-Mobile (40%). (Google Chart). stocks have come roaring back despite millions of people still unemployed due to pandemic-related layoffs and the threat of COVID-19 lurking. The S&P 500 was up more than 1% Monday as it returns to pre-COVID-19 levels following a massive drop in March due to the global pandemic.

Presenting the 2020 GeekWire Awards finalists: Who will be named the best in Pacific NW tech?

GeekWire

The finalists are: Adaptive Biotechnologies prices IPO at $20 per share. This pioneering health, life science, biotechnology or medical breakthrough holds great promise for making the lives of people better or improving the health care system. Sana Biotechnology. Voting is closed and the ballots are tallied. Now, the show must go on. The 2020 GeekWire Awards will take place at 4 p.m.

Tech in 2020 and beyond: What we’ve learned at the GeekWire Summit, and what to expect this week

GeekWire

Fireside chat with Steve Harr, CEO of Sana Biotechnology. Founded by veterans of Juno Therapeutics, Sana Biotechnology is developing new ways to modify genes and replace damaged cells in the body, possibly pioneering new treatments for a number of diseases.

Fred Hutchinson Cancer Research Center cutting 76 jobs, citing impact of economic downturn

GeekWire

The institution is a life sciences and biotech powerhouse in the Seattle region, spinning off numerous startups and providing the scientific underpinnings for major companies including Adaptive Biotechnologies and Juno Therapeutics. The Fred Hutchinson Cancer Research Center’s headquarters in Seattle’s South Lake Union neighborhood. Fred Hutch Photo).